Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines
Irene V. Bijnsdorp(Amsterdam Neuroscience), Godefridus J. Peters(Gdańsk Medical University)
Cited by 30
Related Papers
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834
Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
|European Journal of Cancer and Clinical Oncology|1991|460
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2002|430
Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
|Drug Resistance Updates|2002|353